{
    "cancelStatus": "1",
    "cancelDate": "2020-04-10",
    "cancelReason": [
        "866"
    ],
    "licid": "06019938",
    "validDate": "2019-01-22 00:00:00.000",
    "issueDate": "2009-01-22 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00601993807",
    "prodNameC": "“西門子”革蘭氏陰性尿液協同快速複合板 2 型",
    "prodNameE": "Synergies plus Neg\/ Urine Combo Panel Type 2",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "Antimicrobial agents (μg\/mL)：\\nAmikacin 16-32, Amoxicillin\/K Clavulanate 8\/4-16\/8, Ampicillin 2-16, Aztreonam 8-16, Cefepime 8-16, Cefotaxime 2,8-32, Cefotaxime\/ K Clavulanate 0.5\/4, 4\/4, Cefoxitin 8-16, Ceftazidime 2-16,  Ceftazidime (ESBL Confirmation) 1,8, Ceftazidime\/ K Clavulanate 0.25\/4, 2\/4, Ceftriaxone 8,32, Cefuroxime 4-16, Ciprofloxacin 1-2, Gatifloxacin 2-4, Gentamicin 2-8, Imipenem 4-8, Levofloxacin 2-4, Nitrofurantoin 32-64, Piperacillin\/Tazobactam 16\/4, 64\/4, Ticarcillin\/K Clavulanate 16\/2, 64\/2, Tobramycin 2-8, Trimethoprim\/ Sulfamethoxazole 2\/38"
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "西門子股份有限公司",
    "applicantAddr": "台北市南港區園區街３號８樓",
    "medClass": "2",
    "efficacy": "定性及\/或定量測定快速生長之需氧及兼性厭氧格蘭氏陰性桿菌 (腸細菌科中不具葡萄糖發酵能力者及腸細菌科以外具葡萄糖發酵能力者)的抗藥性，及\/或對於在固態培養基上長出之菌落鑑定至種的層級。 ",
    "mdFormat": "B1025-112：20 tests\/kit",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "C",
            "mdKindMCodeName": "C 免疫學及微生物學裝置",
            "mdKindDCode": "C.1645",
            "mdKindDCodeName": "C.1645 全自動短孵育期抗生素感受性試驗系統",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "SIEMENS HEALTHCARE DIAGNOSTICS INC.",
            "factoryAddr": "2040 ENTERPRISE BLVD., WEST SACRAMENTO, CA 95691, USA",
            "factoryCompanyAddr": null,
            "countryCode": "US",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MUS1131000",
            "factoryInfo": "1",
            "qsd": "QSD4235"
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "Antimicrobial agents (μg\/mL)：\\nAmikacin 16-32, Amoxicillin\/K Clavulanate 8\/4-16\/8, Ampicillin 2-16, Aztreonam 8-16, Cefepime 8-16, Cefotaxime 2,8-32, Cefotaxime\/ K Clavulanate 0.5\/4, 4\/4, Cefoxitin 8-16, Ceftazidime 2-16,  Ceftazidime (ESBL Confirmation) 1,8, Ceftazidime\/ K Clavulanate 0.25\/4, 2\/4, Ceftriaxone 8,32, Cefuroxime 4-16, Ciprofloxacin 1-2, Gatifloxacin 2-4, Gentamicin 2-8, Imipenem 4-8, Levofloxacin 2-4, Nitrofurantoin 32-64, Piperacillin\/Tazobactam 16\/4, 64\/4, Ticarcillin\/K Clavulanate 16\/2, 64\/2, Tobramycin 2-8, Trimethoprim\/ Sulfamethoxazole 2\/38",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [
        {
            "fileType": "1",
            "fileName": "060199380001-102-12-18.pdf",
            "fileStreamId": "01B8EC9D-CC93-47B2-856E-027D987B29E8"
        }
    ],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "D0BC9CEC-DE53-4DB4-93BF-C23220383AE6"
}